Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-08 5:09 pm Unchanged |
2023-02-08 | 13G | Pardes Biosciences, Inc. PRDS |
BML Investment Partners, L.P. | 4,867,984 7.800% |
0 (Unchanged) |
Filing History |
| 2023-02-08 5:06 pm Unchanged |
2023-02-08 | 13G | Graybug Vision, Inc. GRAY |
BML Investment Partners, L.P. | 88,282 5.700% |
0 (Unchanged) |
Filing History |
| 2023-02-08 4:55 pm Purchase |
2023-02-08 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
BML Investment Partners, L.P. | 6,590,000 19.900% |
150,000 (+2.33%) |
Filing History |
| 2023-02-08 4:44 pm Purchase |
2023-02-08 | 13G | Adverum Biotechnologies, Inc. ADVM |
BML Investment Partners, L.P. | 730,018 7.300% |
212,468 (+41.05%) |
Filing History |
| 2023-02-08 4:35 pm Purchase |
2023-02-08 | 13G | Climb Bio, Inc. CLYM |
BML Investment Partners, L.P. | 1,897,614 7.100% |
158,236 (+9.10%) |
Filing History |
| 2023-02-08 4:16 pm Purchase |
2023-02-08 | 13G | Bitwise MARA Option Income Strategy ETF IMRA |
BML Investment Partners, L.P. | 834,444 12.700% |
39,444 (+4.96%) |
Filing History |
| 2023-02-08 4:02 pm Purchase |
2023-02-08 | 13G | Astrotech Corporation ASTC |
BML Investment Partners, L.P. | 5,479,322 13.700% |
5,479,322 (New Position) |
Filing History |
| 2023-02-08 3:43 pm Purchase |
2023-02-08 | 13G | Metacrine, Inc. MTCR |
BML Investment Partners, L.P. | 6,767,458 15.900% |
278,493 (+4.29%) |
Filing History |
| 2023-02-08 3:23 pm Purchase |
2023-02-08 | 13G | Tilly's, Inc. TLYS |
BML Investment Partners, L.P. | 1,234,844 5.500% |
80,000 (+6.93%) |
Filing History |
| 2023-02-08 3:05 pm Sale |
2023-02-08 | 13G | Richardson Electronics, Ltd. RELL |
BML Investment Partners, L.P. | 95,359 0.800% |
-614,641 (-86.57%) |
Filing History |
| 2023-02-08 2:48 pm Purchase |
2023-02-08 | 13G | ARCA biopharma, Inc. ABIO |
BML Investment Partners, L.P. | 71,521 5.950% |
8,033 (+12.65%) |
Filing History |
| 2023-02-08 2:38 pm Sale |
2023-02-08 | 13G | Retractable Technologies, Inc. RVP |
BML Investment Partners, L.P. | 1,056,075 3.200% |
-2,681,425 (-71.74%) |
Filing History |
| 2023-02-02 4:23 pm Purchase |
2023-01-24 | 13G | Surrozen, Inc. SRZN |
BML Investment Partners, L.P. | 111,269 5.600% |
111,269 (New Position) |
Filing History |
| 2023-01-26 4:01 pm Purchase |
2023-01-20 | 13G | CYTEIR THERAPEUTICS INC CYTT |
BML Investment Partners, L.P. | 2,735,973 7.700% |
2,735,973 (New Position) |
Filing History |
| 2023-01-09 12:28 pm Purchase |
2022-12-29 | 13G | Disc Medicine, Inc. IRON |
BML Investment Partners, L.P. | 524,750 3.100% |
524,750 (New Position) |
Filing History |
| 2022-12-30 5:30 pm Purchase |
2022-12-21 | 13G | Pardes Biosciences, Inc. PRDS |
BML Investment Partners, L.P. | 4,867,984 7.800% |
4,867,984 (New Position) |
Filing History |
| 2022-12-08 12:08 pm Purchase |
2022-12-08 | 13D | Metacrine, Inc. MTCR |
BML Investment Partners, L.P. | 6,488,965 15.200% |
976,799 (+17.72%) |
Filing History |
| 2022-12-01 3:43 pm Purchase |
2022-11-22 | 13G | Graybug Vision, Inc. GRAY |
BML Investment Partners, L.P. | 88,282 5.700% |
88,282 (New Position) |
Filing History |
| 2022-11-16 4:45 pm Purchase |
2022-11-14 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
BML Investment Partners, L.P. | 6,440,000 19.400% |
6,440,000 (New Position) |
Filing History |
| 2022-10-26 5:59 pm Purchase |
2022-10-24 | 13G | Metacrine, Inc. MTCR |
BML Investment Partners, L.P. | 5,512,166 12.900% |
3,912,166 (+244.51%) |
Filing History |